Two studies have established an association between the Mediterranean diet and specific microbial communities, finding increased populations of beneficial bacteria such as Faecalibacterium prausnitzii and Roseburia spp
Common gastrointestinal effects reported with GLP-1 therapy include: Nausea (commonly reported, especially during dose escalation) Constipation or diarrhoea Abdominal discomfort or bloating Reduced appetite and early satiety Regarding bowel movement colour specifically, changes in stool colour are not listed as adverse effects in UK SmPCs for GLP-1 receptor agonists
Recent advances in nanodelivery systems of resveratrol and their biomedical and food applications: a review
However, problems such as high drug dependence, complex adverse reactions, poor efficacy, and inability to cure remain prominent (Qindeel et al., 2020)
To help minimize discomfort, it can be beneficial to eat smaller, low-fat meals, stay hydrated, and follow your healthcare providers guidance
This dual agonist approach serves to enhance the bodys natural insulin production only when blood glucose levels are elevated
